Periodontal dressing material
DrugProcedure:Palatal wound area was covered with periodontal dressing material at baseline and 3rd day
Other names: Peripac®
NCT Number: NCT02534415
Aim of the study is to assess the therapeutic effects of topical hyaluronic-acid use on secondary wound healing of the free gingival graft donor site. The hypothesis of this study is that topical hyaluronic-acid gel has positive effects on secondary wound healing of free gingival graft donor site by reducing pain, burning sensation, and accelerating the healing.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
The objective of the randomized, single blind, controlled and parallel clinical trial was to assess therapeutic effects of topical hyaluronic-acid on secondary wound healing of free gingival graft donor site.
Primary outcome variables that pain and burning sensation changes were assessed at 3, 7, 14, 21 days after surgery by the examiner. Pain and burning sensation were assessed by patients using the VAS, score 0 indicate no pain or burning sensation, score 10 indicate severe pain or burning sensation. Secondary outcome variables included color match, consistency and epithelization of the wound area. These parameters were assessed by the same examiner at 3, 7, 14, 21 and 42 days after surgery. Color of the palatal mucosa was assessed by comparing it to that of the adjacent and opposite site using the VAS. Score 0 indicate no color match and score 10 indicate very good color match. Consistency of the palatal mucosa was assessed with a blunt instrumentation and scored as soft or firm. Epithelialization was scored clinically as none, partial or complete.
Sample size has been estimated in 12 subjects per treatment groups. Random allocation of the treatment sites to test and control groups will be performed using a computerized selection of random numbers for allocation of the study groups.
Clinical images obtained at baseline, 3, 7, 14, 21 and 42 days after surgery from each treatment site.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Procedure:Palatal wound area was covered with periodontal dressing material at baseline and 3rd day
Other names: Peripac®
0.2% topical hyaluronic-acid gel was applied to palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day
Other names: Gengigel
0.8% topical hyaluronic-acid gel was applied palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day
Other names: Gengigel
Time frame: 21 days
Using a visual analog scale (0: No pain, 10: Severe pain)
Time frame: 42 days
Using a visual analog scale (0: No color match, 10: Good color match) (Adjacent and opposite site)
Time frame: 42 days
Soft/firm
Time frame: 42 days
None/partial/complete
Time frame: 21 days
Using a visual analog scale (0: No burning sensation, 10: Severe burning sensation)
Marmara University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724145
Estradiol, Wound Healing
Geneva, Switzerland
View Trial DetailsNCT07645547
Dehiscence, Hematoma
View Trial DetailsNCT07615517
Infections, Pathologic Processes
Augsburg, Bavaria, Germany
View Trial DetailsNCT07571408
Cold Atmospheric Plasma, Peripheral Occlusive Disease
Cologne, North Rhine-Westphalia, Germany
View Trial Details